Lisa Gill
Stock Analyst at JP Morgan
(3.54)
# 886
Out of 5,090 analysts
133
Total ratings
52.69%
Success rate
4.63%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Maintains: Overweight | $32 → $33 | $23.92 | +37.96% | 6 | Nov 13, 2025 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $6 → $5 | $2.75 | +81.69% | 2 | Nov 11, 2025 | |
| PGNY Progyny | Maintains: Neutral | $25 → $26 | $24.01 | +8.29% | 1 | Nov 11, 2025 | |
| COR Cencora | Maintains: Overweight | $344 → $417 | $337.63 | +23.51% | 3 | Nov 11, 2025 | |
| LH Labcorp Holdings | Maintains: Overweight | $291 → $317 | $261.48 | +21.23% | 2 | Nov 7, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $17 → $18 | $19.37 | -7.05% | 5 | Nov 5, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $428 → $375 | $268.42 | +39.71% | 14 | Nov 4, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $384 → $394 | $333.49 | +18.14% | 6 | Oct 28, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $310 → $425 | $333.49 | +27.44% | 10 | Oct 9, 2025 | |
| MCK McKesson | Maintains: Overweight | $821 → $853 | $814.18 | +4.77% | 14 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $10 | $9.12 | +9.71% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $7 → $6 | $2.55 | +135.29% | 5 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $184.18 | +3.16% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $19.54 | +53.53% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $41 | $29.73 | +37.91% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $253.02 | +1.18% | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $81 | $76.75 | +5.54% | 5 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $142 → $145 | $199.19 | -27.21% | 6 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $31.49 | -42.84% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $5.16 | -3.01% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $17.36 | +61.29% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $7.78 | +15.68% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $8.87 | +102.93% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $150.57 | +162.34% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $230.59 | -19.34% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $212.14 | -34.01% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $487.66 | -31.92% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $0.73 | +1,136.26% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $6.46 | +23.93% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $73.13 | +13.50% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $38.85 | +152.25% | 1 | Jan 6, 2023 |
Privia Health Group
Nov 13, 2025
Maintains: Overweight
Price Target: $32 → $33
Current: $23.92
Upside: +37.96%
GoodRx Holdings
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.75
Upside: +81.69%
Progyny
Nov 11, 2025
Maintains: Neutral
Price Target: $25 → $26
Current: $24.01
Upside: +8.29%
Cencora
Nov 11, 2025
Maintains: Overweight
Price Target: $344 → $417
Current: $337.63
Upside: +23.51%
Labcorp Holdings
Nov 7, 2025
Maintains: Overweight
Price Target: $291 → $317
Current: $261.48
Upside: +21.23%
Alignment Healthcare
Nov 5, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $19.37
Upside: -7.05%
The Cigna Group
Nov 4, 2025
Maintains: Overweight
Price Target: $428 → $375
Current: $268.42
Upside: +39.71%
Elevance Health
Oct 28, 2025
Maintains: Overweight
Price Target: $384 → $394
Current: $333.49
Upside: +18.14%
UnitedHealth Group
Oct 9, 2025
Maintains: Overweight
Price Target: $310 → $425
Current: $333.49
Upside: +27.44%
McKesson
Sep 26, 2025
Maintains: Overweight
Price Target: $821 → $853
Current: $814.18
Upside: +4.77%
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $9.12
Upside: +9.71%
Aug 27, 2025
Maintains: Underweight
Price Target: $7 → $6
Current: $2.55
Upside: +135.29%
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $184.18
Upside: +3.16%
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $19.54
Upside: +53.53%
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $29.73
Upside: +37.91%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $253.02
Upside: +1.18%
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $76.75
Upside: +5.54%
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $199.19
Upside: -27.21%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $31.49
Upside: -42.84%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $5.16
Upside: -3.01%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $17.36
Upside: +61.29%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $7.78
Upside: +15.68%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $8.87
Upside: +102.93%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $150.57
Upside: +162.34%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $230.59
Upside: -19.34%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $212.14
Upside: -34.01%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $487.66
Upside: -31.92%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $0.73
Upside: +1,136.26%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $6.46
Upside: +23.93%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $73.13
Upside: +13.50%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $38.85
Upside: +152.25%